ARCHIMED
Antonio Sánchez-Cordero serves as Principal at ARCHIMED since March 2024, bringing extensive experience in business development and corporate strategy from previous roles, including Group Vice President of Strategy & Business Development (M&A) at Thermo Fisher Scientific and Worldwide Vice President of Business Development (M&A) at BD. With a strong foundation in strategy and marketing, Antonio has held senior positions at PDI, Ampersand Capital Partners, and Werfen, among others. Academic accomplishments include several executive programs at Harvard Business School and an MBA in Strategy & Marketing from Esade, as well as legal studies at Universitat Pompeu Fabra.
This person is not in the org chart
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.